Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Baylor Health Care System
- Registration Number
- NCT00003792
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Baylor Health Care System
- Registration Number
- NCT00017355
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
News
PARTNER 3 Trial Shows TAVR Maintains Equivalent Outcomes to Surgery at 7 Years in Low-Risk Patients
The PARTNER 3 trial demonstrates that transcatheter aortic valve replacement (TAVR) provides similar clinical outcomes to surgery at 7 years in low-risk patients with severe aortic stenosis.